Effects of Androgen Treatment on Expression of Macrophage Fcγ Receptors
Lab / animal
OA: diamond
CC0
AI-generated summary
Androgen treatment reduced guinea pig splenic macrophage Fcγ receptor expression and impaired IgG-sensitized erythrocyte clearance, while antiandrogens had no significant effect but counteracted androgenic effects.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ABSTRACT Macrophage Fcγ receptors (FcγRs) play an important role in the host defense against infection and in the pathophysiology of immune cytopenias. Modulation of macrophage FcγR expression is a potential therapeutic approach to immune disorders. Glucocorticoids and progesterones decrease macrophage FcγR expression. We assessed the effect of treatment with androgens and antiandrogens on the expression of macrophage FcγRs using an experimental guinea pig model. Four androgens (testosterone, dihydrotestosterone, mesterolone, and danazol) and five antiandrogens (flutamide, nilutamide, cyproterone acetate, spironolactone, and finasteride) were studied. Following in vivo treatment of guinea pigs, we determined the clearance of immunoglobulin G (IgG)-sensitized erythrocytes in vivo, the binding of IgG-sensitized erythrocytes by isolated splenic macrophages, and splenic macrophage FcγR cell surface expression. All of the androgens impaired the clearance of IgG-sensitized erythrocytes by decreasing splenic macrophage FcγR expression. Dihydrotestosterone and mesterolone were more effective than testosterone or dihydrotestosterone. Flow cytometry and fluorescence microscopy with monoclonal antibodies demonstrated that the androgens decreased the cell surface expression of FcγR1,2 more than that of FcγR2. Antiandrogens did not significantly alter macrophage FcγR expression. Nevertheless, antiandrogens counteracted the effects of androgens on macrophage FcγR expression. These data indicate that androgens impair the clearance of IgG-coated cells by decreasing splenic macrophage FcγR expression. Thus, androgens other than danazol are candidate drugs for the treatment of immune disorders.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (36)
- doi:10.1172/jci111669 via openalex
- doi:10.1016/s0074-7696(08)60202-8 via openalex
- doi:10.1172/jci106846 via openalex
- doi:10.1172/jci108196 via openalex
- doi:10.1056/nejm199411033311807 via openalex
- doi:10.1056/nejm199401133300208 via openalex
- doi:10.1002/art.1780280202 via openalex
- doi:10.1006/clin.1998.4602 via openalex
- doi:10.1084/jem.147.6.1684 via openalex
- doi:10.1056/nejm199410273311704 via openalex
- doi:10.1016/0161-5890(87)90112-x via openalex
- W191597747 via openalex
- doi:10.1016/s0065-2776(08)60329-6 via openalex
- W130210025 via openalex
- W156778026 via openalex
- doi:10.4049/jimmunol.141.9.2959 via openalex
- doi:10.1172/jci107325 via openalex
- doi:10.1002/eji.1830111008 via openalex
- doi:10.1056/nejm198205273062102 via openalex
- W2258056387 via openalex
- W2417970686 via openalex
- doi:10.4049/jimmunol.132.2.745 via openalex
- doi:10.1016/0002-9378(56)90613-5 via openalex
- doi:10.1182/blood.v62.2.480.480 via openalex
- doi:10.1095/biolreprod26.1.1 via openalex
- doi:10.1016/s0140-6736(94)92205-5 via openalex
- doi:10.1172/jci106847 via openalex
- doi:10.1016/0002-9378(60)90375-6 via openalex
- doi:10.1097/00006254-196310000-00001 via openalex
- doi:10.1111/j.1471-0528.1954.tb07707.x via openalex
- doi:10.1126/science.3871252 via openalex
- doi:10.1111/j.1600-065x.1983.tb01093.x via openalex
- doi:10.1056/nejm199003153221102 via openalex
- doi:10.1172/jci115271 via openalex
- doi:10.1006/clim.1998.4665 via openalex
- doi:10.1002/1097-0142(19931215)72:12+<3810::aid-cncr2820721710>3.0.co;2-o via openalex
Source provenance
- openalex
- last seen: 2026-05-11T04:51:27.821502+00:00
License: CC0
· commercial use OK